LATS2 and lung adenocarcinoma: PVT1 recruited EZH2 to the large tumor suppressor kinase 2 (LATS2) promoter and repressed LATS2 transcription, and PVT1/EZH2/LATS2 interactions might serve as new target for lung adenocarcinoma diagnosis and therapy [21].